Completed OBSERVATIONAL NCT00651183

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

Sponsor: Boehringer Ingelheim

Interventions Pramipexole immediate release

Updated 7 times since 2017 Last updated: May 9, 2014 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Parkinson Disease and is currently completed. Boehringer Ingelheim leads this study, which shows 7 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amstetten, Austria , Bad Hall, Austria , Bad Ischl, Austria , Bad Radkersburg, Austria , Baden, Austria , Bregenz, Austria , Bruck an der Mur, Austria , Deutschlandsberg, Austria , Dornbirn, Austria , Eisenstadt, Austria and 47 more locations